LOGIN
Intra-articular Injections of Hylan G-F 20 for Pain in Patients with Idiopathic Knee Osteoarthritis
December 2024
Intra-articular Injections of Hylan G-F 20 for Pain in Patients with Idiopathic Knee Osteoarthritis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled tri
Drugs Context. 2024 01-Apr;():. 10.7573/dic.2023-11-3Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty patients with chronic idiopathic knee osteoarthritis (Larsen grade II or III) were randomized to receive three once-weekly intra-articular injections of either Hylan G-F 20 (n=15) or placebo (n=15). The primary outcome was pain relief as assessed by visual analogue scale (VAS) scores at weeks 12 and 26. Secondary outcomes included patient activity level, overall clinical condition, and adve...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.